CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer

Investigator(s):
Edward B Garon, MD, MS;
Organization: 
UCLA
NCT Number: 
Disease Name: 
Non-small cell lung cancer
Disease Category: 
Trial Phases: 
Phase 1
Trial Status: 
Recruiting
Trial Contact: 

Edward B Garon, MD, MS